H.B. Fuller Company (FUL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Mar, 2026Voting matters and shareholder proposals
Election of three directors for a three-year term until the 2029 Annual Meeting, with nominees Daniel L. Florness, Celine C. Martin, and Teresa J. Rasmussen.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending November 28, 2026.
Non-binding advisory vote to approve the compensation of named executive officers.
Proxies may vote at their discretion on any other matters that properly come before the meeting.
Board of directors and corporate governance
Three Class III directors are nominated for election, each to serve until 2029 or until a successor is elected or qualified.
Executive compensation and say-on-pay
Shareholders are asked to approve, on an advisory basis, the compensation of named executive officers as disclosed in the proxy statement.
Latest events from H.B. Fuller Company
- Q2 2026 saw strong revenue, margin, and EPS growth, with a major medical acquisition announced.FUL
Q2 2026 - All proposals passed, including director elections and auditor ratification, with no shareholder questions.FUL
AGM 2026 - Adjusted EBITDA and EPS rose with margin expansion despite a 6.6% organic revenue decline.FUL
Q1 2026 - Proxy covers director elections, auditor ratification, pay, strong results, and ESG focus.FUL
Proxy Filing - Margin and EPS growth achieved through cost actions and acquisitions despite revenue headwinds.FUL
Q4 2025 - Adjusted EBITDA and EPS grew 5% year-over-year, with margin gains and raised full-year guidance.FUL
Q2 2025 - Q3 2024 saw 6% EBITDA and 7% EPS growth, led by strong Construction Adhesives results.FUL
Q3 2024 - Adjusted EPS up 20% and EBITDA up 10% year-over-year, with 2024 guidance raised.FUL
Q2 2024 - FY24 revenue up 1.6%, margin at 16.6%; 2025 outlook cautious with cost and footprint actions.FUL
Q4 2024